What must be borne in mind before implantation?
Because people with dental implants who are IL-1 positive are particularly sensitive to pathogenic bacteria, prior knowledge of the patient’s tendency to inflammation can have a considerable influence on the success of treatment. These patients should avoid additional risk factors as far as possible, for example, and be integrated into a regular recall system. If implantation is planned for a patient who smokes and who has already suffered tooth loss as a result of periodontitis, determination of the IL-1 genotype is strongly recommended. For the implantologist, testing represents an opportunity to safeguard against implant loss and potential claims for compensation.